Diagnosis And Management Of Orthopedic Implant

2y ago
18 Views
2 Downloads
646.66 KB
11 Pages
Last View : 1m ago
Last Download : 3m ago
Upload by : Milena Petrie
Transcription

Biomedical Research 2017; 28 (11): 5063-5073ISSN 0970-938Xwww.biomedres.infoDiagnosis and management of orthopedic implant-associated infection: acomprehensive review of the literature.Rares Mircea Birlutiu1,2, Victoria Birlutiu1,3*, Manuela Mihalache1, Cosmin Mihalache1,4, RazvanSilviu Cismasiu2,51LucianBlaga University of Sibiu, Faculty of Medicine Sibiu, Romania2FOISORClinical Hospital of Orthopedics, Traumatology, and Osteoarticular TB Bucharest, Romania3Departmentof Infectious Diseases, Academic Emergency Hospital Sibiu, Romania4Departmentof Nuclear Medicine, Academic Emergency Hospital Sibiu, Romania5CarolDavila University of Medicine and Pharmacy Bucharest, RomaniaAbstractOrthopedic surgery of total hip and total knee arthroplasty were the most successful orthopedicsurgeries of the last century. In the context of an increase number of primary and revision total hip andtotal knee arthroplasty performed each year, an increased risk of complication is expected. The aim ofour review is to present comprehensive data form the literature regarding the diagnosis strategies(according to the international guideline for the diagnosis of biofilm infections) and treatment strategies(irrigation and debridement with retention of components, one-stage or two-stage revision) forprosthetic joint infection. A MEDLINE via PubMed, Scopus, and Web of Science search for original andreview articles was performed using key terms, prosthetic joint infection, PJI, biofilm, total hiparthroplasty, total knee arthroplasty, diagnosis, and treatment. Prosthetic joint infection, still, remainsthe most common and feared arthroplasty complication. Recent studies have shown that the formationof biofilm by pathogens is involved in prosthetic joint infection, infections that are acquired either via anexogenous or an endogenous pathway. The diagnosis and treatment of prosthetic joint infection remainsa challenge. A correct diagnosis of infection is decisive for a correct treatment of orthopedic implantrelated infections.Keywords: Prosthetic joint infection, PJI, Total hip arthroplasty, Total knee arthroplasty, Diagnosis, Treatment.Accepted on April 4, 2017IntroductionOrthopedic surgery of total hip and total knee arthroplastywere the most successful orthopedic surgeries of the lastcentury, surgeries with a primary purpose of restoring the jointfunction of persons affected by osteoarthritis. Arthroplastysurgeries have a significant effect on the quality of life, onreducing symptoms, on regaining physical function, and onimproving mobility and regaining the independence of dailyroutines [1]. The number of arthroplasty surgeries is increasingfrom year to year, in 2010, in the US 719.000 interventions ofTotal Hip Arthroplasties (THA) [2], and in 2012, 600.000interventions of Total Knee Arthroplasties (TKA) wereperformed [3]. In Romania, according to the RomanianArthroplasty Register, in 2014 were reported to be performed10.179 primary surgeries of THA, and 2.619 primary surgeriesof TKA. In 2015, according to the same register, 9.297 THAand 2.770 TKA primary interventions were conducted. In thiscontext of an increase number of primary surgeries, inBiomed Res- India 2017 Volume 28 Issue 11Romania, during 01.01.2014-01.01-2016, 1.164 hip and 167knee revision surgeries were performed.With an increasing number of primary and revision THA andTKA performed each year there is an expected increased riskof complication. One of the most serious complications, still,remains Prosthetic Joint Infection (PJI). Infections that canoccur despite well-established hospital cleaning, disinfectionpolicies and procedures, the conditions of prosthesismanufacturing or antibiotic prophylaxis prior to surgery,measures that are helping to reduce the rate of infection. PJIare devastating complications after arthroplasties, and areassociated with an increased rate of morbidity and mortality.According to the data published in the literature, orthopedicimplant-associated infection rate is between 1-9%, nearlydoubling for revision surgeries. According to Montanaro et al.,a rate of infections between 3.2% and 5.6% [4]. It is consideredthat 0.5-2% of patients develop a biofilm orthopedic implantassociated infection in the first 2 years after surgery [5-7].5063

r authors have reported an average incidence rate ofinfection of 0.25-1% at 1 y after THA, and 0.4-2% TKAprimary surgery [8]. Also, according to the RomanianArthroplasty Register and the first annual report that has beenpublished in October 2013, report the covers over 81.288 hipand 10.752 knee interventions performed between 2001 and2011, early infection rate for hip arthroplasties was 1.6% andfor knee arthroplasties 0%, in terms of delayed infection, therate was 6.8% hip arthroplasties respectively 0% for kneearthroplasties. This 0% is subject to interpretation, anexplanation may be the lack of reporting to the register thereasons for revision surgery of the primary total kneearthroplasty.In terms of etiologic, most commonly isolated germ Staphylococcus aureus (MRSA) or Methicillin-susceptibleStaphylococcus aureus (MSSA). In the US up to 46% ofStaphylococcus aureus strains are methicillin-resistant strainsand up to 23% of strains of Enterococci spp are vancomycinresistant Enterococci. The alarming emergence of theseresistant strains may lead to increased patients’ morbidity andmortality [9]. A correct diagnosis of infection is decisive for acorrect treatment of orthopedic implant-related infections. Theaim of our review is to present comprehensive data form theliterature regarding the diagnosis strategies (according to theinternational guideline for the diagnosis of biofilm infections)and treatment strategies (irrigation and debridement withretention of components, one-stage or two-stage revision) forprosthetic joint infection.completed PRISMA checklist is included as a supplementmaterial file 1 with this publication.Figure 1. PRISMA flow diagram.Literature SearchFor our comprehensive review, we searched MEDLINE viaPubMed (from 2010), Scopus (from 2010), and Web of Science(from 2010). The original search was conducted on January 8,2015 and updated on December 10, 2015. No date restrictionswere used for the search. Our main search terms consisted ofthe terms prosthetic joint infection, PJI, biofilm, total hiparthroplasty, total knee arthroplasty, diagnosis, and treatment.Our inclusion criteria were defined a priori. We included justEnglish-language articles. Experimental, observational, andqualitative studies were considered eligible. Systematicreviews addressing our research were included. Case report,case series, books, book chapters, symposium and conferenceproceedings, essays, editorials, letters, commentaries, narrativereviews, and protocols were excluded. All authors,independently, screened every title and abstract identified.Consensus was reached on decisions to advance studies to fulltext screening, discrepancies were resolved by discussionbetween the authors. Full text versions of eligible studies wereretrieved for detailed review. References from relevantreviews, meta-analysis, overviews of reviews and relevantinternational clinical guidelines were also examined by twoauthors (RMB, VB) to identify potential relevant articles, andincluded. A PRISMA 2009 Flow Diagram is provided asFigure 1. Our search strategy is included as Figure 2. A5064Figure 2. Search strategy.PathogenesisIn terms of pathogenesis, either an acute or a chronic infectioncan be acquired primarily on two pathways: an exogenous pathduring the time of the surgery or in the postoperative period,and an endogenous path-a hematogenic one. Recent studieshave shown that in both cases, the presence of the biofilm isBiomed Res- India 2017 Volume 28 Issue 11

Diagnosis and management of orthopedic implant-associated infection: a comprehensive review of the literatureinvolved. Thus, more than 30 years ago William "Bill"Costeron discovered how bacteria form biofilm, chronicinfections occur as a result of the phenotypic changes in thelifestyle and in the structural organization of bacteria: thebiofilm.The biofilmMore than 65% of the infections are related to biofilm [8].Each year, in the US, over 12 million cases of infectionsassociated with biofilm are reported (BIS Biofilm-relatedInfections), most common being associated with orthopedicimplants [10]. The surface commonly used with orthopedicimplants is made of titanium (or titanium alloy), stainless steel,cobalt chrome, different polymeric biomaterials (ceramics,hydroxyapatite or polyethylene) and polymethylmethaacrylatebone cement, surfaces that represent structures likely to becolonized and consequently bacterial biofilm is formed [8,11].The biofilm is a structure consisting of bacterial cells (one ormore microorganism species) surrounded by a matrix producedby the bacteria after their adhesion to surface of the implants.The matrix is composed of polymeric secreted compoundscalled Extracellular Polymeric Substance (ESP) orexopolysaccharide like: polysaccharides, proteins, acids, lipidsand extracellular DNA (eDNA). The biofilm is composed of30% bacteria and 70% matrix with protective and adhesionrole [12]. Both bacteria and fungi can cause infectionsassociated with biofilm formation [13]. The biofilm is mainlyresponsible for chronic infections, infections that arecharacterized by persistence and progression, mainly due to theinflammatory response from around the biofilm. Theinflammatory response is mediated by polymorphonuclear andmononuclear cells depending on the type of predominantimmune response-type 2 T helper or type 1 T helper(polarized) lymphocytes [14-16]. Reduced activity of theantibiotics in the biofilm is not fully elucidated. It is consideredthat a dormant state or slow growth of bacteria, the presence ofdifferent bacterial subpopulations in terms of phenotypicantibiotic resistance, gene expression and an increased stresscaused by environmental conditions are contributing factors toan increased resistance to antibiotics.There are four stages of biofilm development on orthopedicimplants:1. Primary cell adhesion: With an onset seconds after theorthopedic implant is removed from the packaging and up to 2h after the exposure to the external environmental conditions.After placing components in their final position, fibrinogen,fibronectin and vitronectin are absorbed on the surface of theimplant creating favorable conditions for biofilm development.2. Cellular aggregation: Consists of a multilayer proliferationof bacteria and adhesion, resulting bacterial colonies, which aresurrounded by a polysaccharide (polysaccharide intercellularadhesion) matrix.3. Biofilm maturation: Reaching the stage of maturation,changes in the mobility structures of the bacteria appear (cilia,Biomed Res- India 2017 Volume 28 Issue 11flagella) and also in the exopolysaccharides. Thus the biofilmwith an increased resistance appears.4. Cell detaching stage: At maturity, planktonic structures canbe released from the mature biofilm, and the same processbegins.Classification Schemes of Prosthetic ImplantAssociated InfectionsThe most commonly used classification of PJIs is the oneproposed by Trampuz and Zimmerli [17,18], depending on theonset of symptoms after arthroplasty and defines the PJIs asearly (occurring within 3 months postoperatively)-commonlycaused by Staphylococcus aureus or gram-negative bacteria,delayed (3-24 months) often caused by bacteria with a lowervirulence, such as coagulase-negative Staphylococci andPropionibacterium acnes and late ( 24 months) caused byStaphylococcus spp., Streptococcus spp. or gram-negativebacteria. Depending on the type of infection PJIs are defined asacute hematogenous PJI (less than 3 weeks’ duration ofsymptoms in the context of an uneventful postarthoplastyperiod), early postinterventional (within 1 month after aninvasive procedure) and chronic PJI. Parvizi et al. mentioned aperiod of 3 months after performing arthroplasty as the cut-offto determine whether the infection can be regarded as beingacute or not [19].In the 1990s, Tsukayama proposed another classification basedon the time since the surgical intervention and the mode ofinfection, first category–positive intraopeative cultures (whenthe surgical revision was presumed to be for an aseptic failure),second category-early postoperative infection ( 1 month aftersurgical intervention), third category-late chronic PJI ( 1monthafter surgery), and forth category-acute haematogenousinfection. There is also a treatment suggested based on themode of presentation: first category-antibiotic therapy, secondcategory-debridement and prosthetic retention, third categoryprosthetic removal, and forth category-debridement andprosthetic retention or prosthetic removal [20,21]. Issuesregarding the selection of a medical, surgical treatment arediscussed in management of prosthetic joint infection, below.McPherson and colleagues popularized another classificationfor PJI that categorizes the type of infection and the host(similar to the Cierny-Mader staging for osteomyelitis). Theclassification includes three of the type of infection proposedby Tsukayama (early postoperative infection, hematogenousinfection, and late chronic infection) [22-24]. The classificationmay assist the surgeon in identifying the severity of theinfection and choose an appropriate treatment option. Thesystem has been used in clinical practise especially in theUnited States and the United Kingdom (Table 1).Definition and Diagnosis of PJIsBoth early and late infections are associated withinterventins, both showing local and generalassociated with changes in biomarkers levels:Protein (CRP), Erythrocyte Sedimentation Ratethe surgicalsymptoms,C-Reactive(ESR) and5065

e Blood Cell (WBC) counts. Blood cultures and tissuecultures can be used in diagnosis. There is no generally validdefinition of the infection associated with orthopedic implantsbut the American Society of Infectious Diseases and theworking groups of the European Society of ClinicalMicrobiology and Infectious Diseases (ESCMID) recommendsthe suspicion of an infection when: sinus tract communicatingis present or is persistent and active, acute pain at the level ofthe prosthetic joint or whenever chronic pain after surgery,especially in the absence of periods without pain, andespecially after surgery.ESCMID recommendations are based on strength ofrecommendation as follows: Grade A-ESCMID stronglysupports a recommendation for use, B-moderately supports, Clow support, D-not recommended; and recommendation onquality of evidence 1-data from at least one randomized study,2-data from at least one study with good design and nonrandomized, cohort or case-control studies or from dramaticresults from uncontrolled experiments, 3-data provided by theauthorities based on clinical studies and clinical cases [25].Also the American Academy of Orthopedic Surgeons (AAOS)and the Centers for Disease Control and Prevention (CDC)published guidelines to establish a consensus on the definitionand diagnostic criteria for orthopedic implants associated(Tables 2 and 3).Table 1. Staging system for prosthetic implant-associated infections according to McPherson [23].Infection typeSystemic host gradeLocal extremity gradeI: early postoperative infection ( 4 postoperative weeks)A: uncompromised1: uncompromisedII: hematogenous infection ( 4 weeks duration)B: compromised (1-2 compromising factors)2: compromised (1-2 compromising factors)III: late chronic infection ( 4 weeks duration)C: significant compromise ( 2 compromising 3: significant compromise ( 2 compromising factors)factors) or one of-absolute neutrophil count 1000/mm3-CD4 T cell count 100/mm3Local extremity grade (wound)-intravenous drug abuse-active infection present-chronic active infection at another site 3-4 months-dysplasia or neoplasm of the immune systemCompromising factors:-multiple incision with skin bridges-age 80-soft tissue loss from prior trauma-immunosuppressive drugs-subcutaneous abscess 8 cm2-alcoholism-malignancy-chronic active dermatitis or cellulites-pulmonary insufficiency-synovial cutaneous fistula-prior periarticular fracture or trauma about a joint-prior local irradiation-chronic indwelling catheter-renal failure requiring dialysis-vascular insufficiency to extremity-chronic malnutrition-systemic inflammatory disease-current nicotine use-systemic immune compromise-diabetes-hepatic insufficiencyTable 2. Definition of strength and quality of recommendations [26].Strength of recommendation:Grade A: ESCMID strongly supports a recommendation for useGrade B: ESCMID moderately supports a recommendation for useGrade C: ESCMID marginally supports a recommendation for useGrade D: ESCMID supports a recommendation against useQuality of evidence:5066Biomed Res- India 2017 Volume 28 Issue 11

Diagnosis and management of orthopedic implant-associated infection: a comprehensive review of the literatureLevel I: Evidence from at least one properly designed randomized controlled trial.Level IIa: Evidence from at least one well-designed clinical trial, without randomized; from cohort or case-control analytic studies (preferably from more than one center);from multiple time series; or from dramatic results of uncontrolled experimentsLevel III: Evidence from opinions of respected authorities, based on clinical experience, descriptive case studies.aAddedindex:Meta-analysis or systematic review of randomized controlled trails.Transferred evidence, that is, results from different patient cohorts, or similar immune-status situation.Comparator group is a historical control.Uncontrolled trail.Published abstracts (presented at an international symposium og meeting)In terms of the clinical picture there are two types of infectionmanifestations: an acute and an oligo-symptomatic one. Theacute manifestations are: fever and chills (symptoms caused bybacteremia), local Celsian signs, joint swelling or active fistula(an active sinus tract communication). When the source ofinfection is a haematogenous one, initially systemicmanifestations dominate the clinical picture and then the localones as in endocarditis, pneumonia or urospesis. Oligosymptomatic infections are harder to be distinguished from anaseptic loosening or in case of exceeding the life of theprosthesis, and are characterized by chronic pain, low gradefever, joint swelling, and radiographic signs of loosening.The presence of some risk factors such as: diabetes, obesity,malnutrition, rheumatoid arthritis, immunosuppression, pastsurgical history, malnutrition, active liver pathology, chronickidney disease, smoking, alcohol consumption, intravenousdrug abuse, recent hospitalization, prolonged hospitalization inrecovery centers and male gender, but also factors that arerelated to the initial surgery (surgical duration, revisionsurgery, absence of prophylactic antibiotics, postoperativehematoma, wound dehiscence) may suggest the diagnosis ofinfection [27]. Patients that are nasal carriers ofStaphylococcus aureus are at increased risk for health careassociated infections, patients with an increased nasalcolonization have a risk of orthopedic implant-associatedinfection 3 to 6 times higher than those with a low level orwithout nasal colonization [28].According to the latest consensus of the MusculoskeletalInfection Society definite PJI exists when:There is a sinus tract communicating with the prosthesis; or apathogen is isolated by culture from at least two separate tissueor fluid samples obtained from the affected prosthetic joint; orFour of the following six criteria exist: -Elevated serumErythrocyte Sedimentation Rate (ESR) and serum C-ReactiveProtein (CRP) concentration, -Elevated synovial leukocytecount, -Elevated synovial neutrophil percentage (PMN%), Presence of purulence in the affected joint, -Isolation of amicroorganism in one culture of periprosthetic tissue or fluid,or -Greater than five neutrophils per high-power field in fivehigh-power fields observed from histologic analysis ofBiomed Res- India 2017 Volume 28 Issue 11periprosthetic tissue at X400 magnification. (PJI may bepresent if fewer than four of these criteria are met).In terms of etiology, the most common identified etiologicalagent is Staphylococcus aureus (21-43%), followed bycoagulase-negative staphylococci (17-39%), streptococci(7-12%), Gram-negative bacilli (2-12%), Enterococcus spp.(1-8%), anaerobic bacteria (2-6%), with no identified etiologicagent (4-12%) and Propionibacterium acnes (38%), frequentlyassociated with THA [12].Laboratory diagnosis of PJIsAmong the serological changes in patient’s blood, an ESRgreater than 30 mm/h or a CRP above 10 mg/dl could suggestan acute infection with a sensitivity of 91-97%, a specificity of70-80% and a negative predictive value of 96%, while in thecase of an chronic infections (biofilm associated infection) theusefulness of these markers greatly decreases. The latestAmerican consensus raises a question mark regarding thereferences values of this parameter because of differencesbetween laboratories in which the samples analysed andbecause of the changes of this references values depending onthe age, gender and comorbidities of the patient, may beelevated because of other inflammatory conditions or, may bebetween normal references values in the context of suppressiveantimicrobial therapy or low-virulence organisms; theconsensus also warns on the possibility that these serologicalmarkers might be elevated up to 60 d after surgery [29].However, a normal CRP level along with a normal ESR issuggestive of a very low probability of infection. The roles ofother markers, including interleukin-1 (IL-1) and -6 (IL-6),procalcitonin, and tumor necrosis factor-alpha still remain to beclarified.The synovial fluid study in the case of an orthopedic implantassociated infection can highlight the following changes: aWBC count of greater than 4200/uL and greater than 80%granulocytes in the case of an hip prostheses, and in the case ofthe knee prosthesis a WBC count of greater than 1700/uL andwith gather than 65% polymorphonuclear cells-values that canbe applied for a period that does not exceeds no more than 25067

hs after surgery; above this time line, a WBC count ofmore than 25000/uL is necessary in the case of an PJI [12].The common methods of diagnosis, such as cultures, mostoften do not indicate the presence of a microorganism (asensitivity between 13.4% and 94.8%) depending also on thenumber of samples that are taken during the surgery-ideallyshould be harvested at least 3 specimens, but no more than 5[29]. Thus, according to the European guideline, ESCMIDguideline for diagnosis and treatment of infections associatedwith biofilm, published in 2014 [25], techniques such aselectron microscopy or FISH (Fluorescence in situhybridization) probes and fluorescence microscopy can revealthe presence biofilm with a sensitivity of 80%-100% [8];techniques that can be associated with other non-culture-basedtechniques of fluid and tissue sample analysis through adetection by PCR (Polymerase Chain Reaction), quantitativePCR or multiplex PCR, Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOFMS), pyrosequencing, and next-generation sequencing, not allof this techniques are available for routine diagnostic work inthe clinical microbiological laboratory. From the microscopictechniques that can reveal the presence of biofilm can be used:optical microscopy associated with Gram stains, technique thatreveals the inflammatory cells, microorganisms and the biofilmmatrix (IIA) [16]. Techniques such as Confocal Laser ScanningMicroscopy (CLSM) and Scanning Electron Microscopy(SEM), are the best ways to reveal the presence of the biofilm,techniques that have the disadvantage of being unable to beperformed in a routine manner (BIII) [30]. In addition to thesetechniques, the use of sonication is a cheap method, whichsignificantly increases the diagnosis rate [31]. Followingsonication the number of colony-forming units (CFU) isreported [25]. The orthopedic implant is inserted is a sterilecontainer together with a variable quantity of saline solution orRinger's Lactate solution and then inserted into a sonicationbath where the sonication process produces strong enoughmicro air bubbles that generate the detach of the biofilm fromthe implant surface, thereafter the sonication fluid can becultivated either on solid of fluid culture medium andtechniques like FISH (IIA) or PCR can be applied [32,33].Studies such as those of Bouza et al. and Percival et al. haveshown that through sonication or centrifugation are recoveredmore colony-forming units of Candida spp. than throughbrewing [34,35].In Romania, from 2012 sonication began to be used at TheNational Institute for Infectious Diseases “Prof. Dr. Matei Bals,the only published data is from July 2012-July 2014, study inwhich were included 39 of orthopedic implants (21 hipprostheses, 11 knee prostheses and 7 fixation devices), 9 breastimplants, and 10 other devices (e.g. central venous catheter,drainage tube) [36].Histopathological criteria for the diagnosis of PJI vary widely;there is a consensus according to which the presence of morethan 5 neutrophils/ high power fields at 400X in 5 differentareas creates a significant suspicion of infection.5068Imaging techniques have an adjunctive role in the diagnosis oforthopedic implant-associated infection, plain radiographs areneither sensitive nor specific, but may be helpful in monitoringserial changes over time after implantation, changes such as:radiolucency at the metal-bone interface, loosening(radiolucency at the interface between the prosthesis and thebone cement-PMMA-polymethylmethacrylate), or implantmigration. Imaging techniques like Computed Tomography(CT) scan or Magnetic Resonance Imaging (MRI) may have acontribution to the diagnosis, but a limited one. Radioisotopetechniques as well as positron emission tomography-computedtomography (PET-CT, PET/CT) are more sensitive but withless specificity, due to the possibility of contrast substanceuptake at level of the incision site up to several months aftersurgery [12].Non-specific proinflammatory markers such as C-reactiveprotein, procalcitonin, eritorictelor sedimentation rate,leukocytes or different cytokines, cannot distinguish betweeninfections caused by bacteria in a planktonic or biofilm state(DIII).Synovial biomarkersDeirmengian et al. evaluated 43 biomarkers that couldpotentially be diagnostic for PJI a small subset ofrepresentative aseptic and PJI samples, of these 16 wereselected 16 biomarkers evaluated on a larger subset, thebiomarkers were: human a-defensin 1-3 (a-defensin), IL-1a,IL-1, IL-6, IL-8, IL-10, IL-17, granulocyte colony-stimulatingfactor (G-CSF), Vascular Endothelial Growth Factor (VEGF),CRP, neutrophil elastase 2 (ELA-2), lactoferrin, istin,thrombospondin, and bactericidal/permeability-increasingprotein (BPI). Five biomarkers (a-defensin, ELA-2, BPI,NGAL, and lactoferrin) correctly predicted the diagnosis asdefined by the Musculoskeletal Infection Society criteria,biomarkers that had a sensitivity of 100% (95% CI:88%-100%) and a specificity of 100% (95% CI: 94%-100%)with AUC values of 1.000. In addition eight biomarkers (IL-8,CRP, resistin, thrombospondin, IL-1b, IL-6, IL-10, and IL-1a)demonstrated AUC values of greater than 0.9 [37].Leukocyte Esterase (LE) is an enzyme secreted by activatedneutrophils as a response to infections. Applying synovial fluidto a simple urine strip test and reading the results for LE is tivity 81%-93%; specificity 87%-100%). If the result ofthe LE test is , it is equivalent to synovial white blood cellcount threshold for diagnosing prosthetic joint infection and isconsidered a minor by the International Consensus Meeting onPJI and by the Center for Disease Control and Preventioncriterion for diagnosis of prosthetic joint infection. LE is a fastand inexpensive test. As a technical problem, if the aspiratedsample is bloody, which occurs in about 33% of the cases,centrifugation of the aspirate at 6600 revolutions per minutefor 2-3 min can help separate out red blood cells from thesynovial fluid and make the colorimetric test accurate andtherefore feasible. Elevated synovial level of protein andBiomed Res- India 2017 Volume 28 Issue 11

Diagnosis and management of orthopedic implant-associated infection: a comprehensive review of the literatureglucose and several types of antibiotics may interfere with LEresults [38].α-defensin is a peptide secreted into the synovial fluid byhuman cells. Its antimicrobial effect is via attachment to thepathogen s cell wall. The concentration of α-defensin insynovial fluid is measured with an immunoassay test. The cutoff positive value is 5.2 mg/L or 4.8 µg/ml [37]. The test is notaffected by bloody aspirates, antibiotic therapy, or systemicinflammatory diseases, and has sensitivity and specificity of100% [37,38].Harvesting samples of biological material that shouldbe sent to the clinical microbiological laboratory todetect biofilm infectionsIn the case of infections associated with the surgical site,biopsy tissues are considered the most reliable samples toreveal biofilm. Using a swab to collect a sample of the biofilmfrom the wound surface, is an inappropriate method (DII) dueto contamination with skin flora, the strong adherence of thebiofilm to epithelium, and due to the growth of anaerobicbacteria in the depth of the surgical site/deep tissues. In theabsence of the possibility of obtaining a biopsy from thedebrited wound, it is recommended to obtain biologicalmaterial on a cotton swab from the surface layers

Diagnosis and management of orthopedic implant-associated infection: a comprehensive review of the literature. Rares Mircea Birlutiu1,2, Victoria Birlutiu1,3*, Manuela Mihalache 1, Cosmin Mihalache1,4, Razvan Silviu Cismasiu2,5 1Lucian Blaga University of Sibiu, Faculty of Medicine Sibiu, Romania 2FOISOR Clinical Hospital of Orthopedic

Related Documents:

Orthopedic Associates is a collection of talented, highly trained Orthopedic Surgeons and staff dedicated to serving Ocean County and beyond. Ocean Orthopedic Associates was founded in 1969 by some of the original Orthopedic Surgeons to practice in Ocean County and their commitment to excellence and dedica

What Does That Have To Do With Technology? An Orthopedic Practice can not exist without a properly educated, trained and licensed Orthopedic Surgeon. An Orthopedic Practice can not persist itho tpersist without a properly ed catededucated, trained and equipped Staff to convert the Orthopedic Surgeon's training and abilities

The modern orthopedic hospitalist is an inpatient orthopedic specialist, devoting his or her time and knowledge to the fractures, injuries, and other issues that present to emergency departments as well as among the inpatient floors. An orthopedic hospitalist can address all acute care orthopedic needs. Some of the most commonly

Research related to medical robots for orthopedic sur-gery began in the mid-1980s [1, 2]. The orthopedic medical robots are supposed to play an important role in orthopedic surgery. The role of orthopedic medical robots is divided into two kinds of essential features. The first feature is that the orthopedic medical robots can be used for bone .

Nontraumatic Orthopedic Emergencies Objectives Understand the pathophysiology of nontraumatic orthopedic conditions. Describe the management of nontraumatic pediatric orthopedic problems. Identify radiographic findings helpful in the diagnosis of many

–Identify common pediatric orthopedic emergencies, including fractures, dislocations, infection, and overuse injuries –Choose the correct evaluation tools and initial management for common pediatric orthopedic emergencies –Recognize pediatric orthopedic emergencies that should

STUDY INTO THE NEED TO REGULATE ORTHOPEDIC TECHNOLOGISTS AND ORTHOPEDIC PHYSICIAN'S ASSISTANTS December 17, 2008 Virginia Board of Health Professions 9960 Mayland Dr, Suite 300 Richmond, VA 23233-1463 (804) 367-4400

are required with reduced weight. Experimental tests are executed following ASTM or UNI EN rules, in particular the shear test is executed using a rig constructed to the purpose, designed following the rule ASTM D 4255-83. Besides the tests were simulated by analytical methods, by means of Cadec software and numerically